ACSL6 and neoplasm: Results showed that some of the most relevant pathway’s regulators and effectors (CD36, FABP4, PLIN1, PLIN4, SCD5 and ACSL6) showed significantly lower expression in tumor tissue samples (p.adjusted < 0.01, data not shown).